Article
Mutated recombinant human glucagon-like peptide-1 protects SH-SY5Y cells from apoptosis induced by amyloid-beta peptide (1-42).
Neuroscience letters - 31 Oct 2008
Qin Zhenxia, Sun Zhongwei, Huang Jing, Hu Yinghe, Wu Zirong, Mei Bing
Abstract excerpt
Accumulation and deposition of amyloid beta peptide (Abeta) in the brain causes neuronal apoptosis and eventually leads to Alzheimer's disease (AD). A therapeutic target for AD is to block the cascade reaction induced by Abeta. It has been demonstrated that glucagon-like peptide-1 (GLP-1), which is an endogenous insulinotropic peptide secreted from the gut, binds to its receptor in the brain and possesses...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
